Comparing effects of intravenous and nebulized magnesium sulphate for attenuation of laryngoscopic response
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/02/040690
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
American Society of Anaesthesiologists Physical status (ASA) I-II
Patients undergoing elective surgery under general anaesthesia requiring endotracheal intubation
Exclusion Criteria
Anticipated Difficult laryngoscopy and intubation or more than one attempt for intubation taken.
Patient having cardiovascular dysfunction.
Uncontrolled Hypertensive
Patients with raised intracranial pressure or intraocular pressure
Pre-existing hepatic or renal impairment.
Pregnant patients.
Allergic to Study Drug.
Patient refusal for consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method